unique academic journey—from early interests in medicine to his pivot toward pharmacology and GPCR research His research centers on the beta-2 adrenergic receptor and GPR65 , a proton-sensing receptor with promising better experimental tools in GPCR signaling , and the importance of engaging with the broader GPCR research offering a behind-the-scenes look at a rising scientist’s journey in the ever-evolving world of GPCR research My research has looked at the trafficking and signaling of adrenergic and proton-sensing receptors, with

Silvio Gutkind on keeping a cancer research lab running at 10% occupancy, why rotation students act like Strategic Partner(s) Silvio Gutkind: Building a Lab That Doesn't Shut Down Conversations that happen when a research His research spans GPCR signaling in cancer biology, head and neck squamous cell carcinoma, and the molecular Scientific Themes of the Conversation Institutional resilience and the architecture of a research lab Gutkind describes operating his cancer research building at 93–94% capacity during the early pandemic

GPCR Ecosystem: uniting scientists, biotech, and innovators to advance GPCR research worldwide. Join Free & Get Our Weekly News See Why it Matters 6,600+ followers 200+ Research Labs 1,500+ Scientists GPCR to: Curate relevant data—not overwhelm you with it Connect researchers with CROs, peers, and biotech The GPCR Challenge Scientists waste an average of 12 hours per week searching for relevant GPCR research goals Collaborative by Design Connects researchers, CROs, and biotech teams—not just profiles, real

Alexander Ball of GeneTex on the recombinant platform and validation strategy behind a challenge to GPCR researchers through each, explain why KO/KD testing is prioritized, and show how the validation data is shared with researchers GeneTex is offering free samples of the recombinant antibodies to GPCR researchers in exchange for structured Ball puts it in his own words, the primary goal is to get these reagents tested and evaluated by GPCR researchers He transitioned from clinical medicine to academic research at UC Irvine, where he worked on protein

He is the Research director at INSERM with a specific interest in G protein-coupled receptors by developing He was the director of the French network of GPCRs (GDR-3545), currently directs the International Research receptor » sub-committee, Editor-in-Chief of « Frontiers in Cellular Endocrinology » and AE of « J Pineal Research He is a highly cited researcher – 2019 and 2020 identified by Clarivate Web of Science ™. Dr.

The moment research stopped being a question During his master's at JNU, Dr. Shukla wasn't sure research would be his career. "I was not, to be honest, sure if research was what I wanted to take up as a career. That is where I realized research is what I want to do for the rest of my life." Shukla’s research and how working in the lab instead of going to classes made him realize that research

GPCR unites researchers, industry, and partners to accelerate GPCR science and drug discovery—through What We Do (in Three Verbs) Connect — Researchers, founders, students, and industry partners meet, learn Join To join the community, you should be actively related to the GPCR field , including: Academic researchers Partner perks: Direct interaction with researchers, founders, and decision‑makers Access to all member

She received her Ph.D. at the University of Pittsburgh and continued her postdoctoral research at the Nyla supports biomedical research by connecting researchers with resources and promoting reproducible Prior to his role at Addgene, Jason held roles in academia, big pharma, and non-profit research organizations

He traces the concept to basic work by Susanna Cotecchia on the alpha 1 receptor in the early 1990s, research orphan and adhesion GPCRs - 34:00 The truncation that was supposed to kill signaling - 37:34 Pulling the pin user=tfsXwHUAAAAJ&hl=en&oi=ao - ResearchGate: https://www.researchgate.net/profile/Randy-Hall - A Funny GPCR Ecosystem: https://www.ecosystem.drgpcr.com/search?q=Randy+Hall Unlock the Full Dr.

that antibodies can’t, how to validate functional assay systems, and why fluorescence-based assays paired His postdoctoral training included research at the École Polytechnique Fédérale de Lausanne (2015–2016 ) and later at the Max Planck Institute for Medical Research in Heidelberg, where he served as both postdoc Since 2020, JB has led his research group at the Leibniz Research Institute for Molecular Pharmacology Johannes Broichhagen on the Web LinkedIn Google Scholar Lab Website Leibniz Research Institute for Molecular

Mikel Garcia-Marcos "I was trained as a biochemist and molecular biologist during my Ph.D (2005) in Spain My research aims to understand the mechanisms and consequences cell communication via heterotrimeric Garcia-Marcos shares insights on transitioning from postdoctoral research to leading his own lab, addressing positions and the importance of networking, adaptability, and mentorship in fostering a collaborative research Garcia-Markos reflects on milestones in his research journey, reinforcing the passion that drives scientists

biology—and where it still falls short Advice for junior scientists: what really matters when building a research Listen GPCR scientists and pharmacologists Computational chemists and structural biologists Early-career researchers Carlsson Jens Carlsson is a Professor of Computational Biochemistry at Uppsala University, where his research His journey took him from Sweden to Scripps Research and UCSF, where he was first introduced to GPCRs together chemists, modelers, and biologists to accelerate discovery and train the next generation of GPCR researchers

leading experts to explore their career journeys, groundbreaking discoveries, and the impact of their research Inspire the future – Motivate the next generation to pursue GPCR research. At its core, Dr. Guest In each episode, we chat with an expert about their career trajectory, discoveries, and how their research Carrier paths, choosing research topics, switching fields, late start, failures and successes.

Monash Institute of Pharmaceutical Sciences fosters innovation in functional assay development and GPCR research She established her lab in 2011, and today she is a Viertel Senior Medical Research Fellow. the 2024 ASCEPT Achievement Award, the 2023 BPS Geoffrey Burnstock Prize, and the 2019 Faculty Future Research GPCR Spatial Signaling Sparked a Scientific Journey From Pipettes to Platforms: The Evolution of GPCR Research

Kari Johnson's research follows this receptor from the bench to the behaving animal, using optogenetics The Years Before the Tools Existed For most of the history of GPCR electrophysiology, researchers used Giving the approach a name formalizes it as a research program, not just a technique. The results have not been released to the research community. Kari Johnson on the web LinkedIn Google Scholar Research Gate USU Twitter Dr.

Insights for GPCR researchers and functional assay innovators. << Back to podcast list Strategic Partner This conversation traces her path from circadian rhythm research in Drosophila to mosquito behavior, About Laura Duvall runs a research lab in the Department of Biological Sciences at Columbia University and related GPCRs coordinate circadian clock cells in the Drosophila brain, then moved into mosquito research seeking behavior as a way to block transmission of Zika, dengue, and chikungunya - Building a mosquito research

What challenges do you face most in your research or biotech journey? feedback helps us: Keep events free or affordable Expand our shared knowledge base Support students and researchers entering the field Together, we’re building a home for everyone passionate about GPCR research and innovation

Davide Calebiro "Davide Calebiro is Chair of Molecular Endocrinology and Wellcome Trust Senior Research Fellow at the Institute of Metabolism and Systems Research (IMSR) of the University of Birmingham and He leads a multidisciplinary research team comprising biologists, chemists, physicists, engineers and

pharmacological blockade - and why those properties have shaped both the therapeutic opportunities and the research ABOUT THE GUEST Masha Niv is associate professor and vice dean of research and development at the Hebrew She was also a key contributor to the GCCR consortium's large-scale chemosensory research during the Niv is currently an associate professor and vice dean for research at the Hebrew University of Jerusalem The Niv lab is also part of the Global Consortium for Chemosensory Research.

discovery at Glaxo (now GlaxoSmithKline) before joining UNC Chapel Hill, where he teaches and leads research discovery and development, with 25+ years of expertise and validated cell-based assays spanning basic research engagement opportunities for scientists and biotech leaders working across pharmacology, translational research intelligence on GPCR drug discovery trends and developments Expert-led webinars and masterclasses with leading researchers

Antonella Di Pizio is an independent research group leader in computational pharmacology at the Leibniz So the research is more food-oriented and food-chemistry-oriented — this is why we have knowledge about "You share your research goal with your collaborators. They are more partners than collaborators." Antonella Di Pizio, an independent research group leader at the Leibniz Institute for Food Systems Biology Today, Antonella has expanded her research to olfactory GPCRs and trace amine receptors.

Her research focuses on characterizing the localization, signaling, and in vivo function of previously Since returning to Europe, her research has centered on receptor biology at the intersection of basic If a failed approach were citable, it would shorten the path for the next researcher attempting the same GPCR University mid-roll 06:17 - Life in New York; comparing research cultures across continents 08:30 - How adhesion GPCRs entered the picture, and the shift toward receptor biology 11:49 - Research program

discovery at Glaxo, now GlaxoSmithKline, before joining UNC Chapel Hill, where he teaches and leads research discovery and development, with 25+ years of expertise and validated cell-based assays spanning basic research engagement opportunities for scientists and biotech leaders working across pharmacology, translational research intelligence on GPCR drug discovery trends and developments Expert-led webinars and masterclasses with leading researchers

a molecular pharmacologist at the University of Nottingham, to discuss his scientific journey, GPCR research Folding to GPCRs – How Dmitry transitioned from biophysics and protein folding to cannabinoid receptor research Interdisciplinary Research & Future Directions – Exploring combinatorial drug actions, receptor interactions

the Department of Physiology and Pharmacology at Karolinska Institute in Stockholm, where he leads research Gunnar Schulte Gunnar Schulte is a Professor in receptor pharmacology and research group leader for the Gunnar Schulte is also the scientific secretary of the Swedish Society for Medical Research (SSMF) and General Research Interest: The focus in the Schulte lab is on Frizzled signaling and pharmacology aiming Most importantly my research team tries to understand underlying mechanisms of WNT-receptor interaction

Since then Oliver has worked at the University of Geneva, where his research on peptide engineering and high-profile publications and new intellectual property, and at the Mintaka Foundation for Medical Research

Join the Adhesion GPCR Workshop 2024 in Mexico City at CINVESTAV, bringing together researchers to explore venue, CINVESTAV - Centro de Investigación y de Estudios Avanzados del IPN (in English: Center for Research

. 💼 Job Board & Career Growth Helping researchers and biotech companies find the right opportunities $25 $1,000 Catalyst Funds scholarships, retreats, and mentorship opportunities for early-career GPCR researchers $250 $5,000+ Visionary Powers new educational initiatives and programs that shape the future of GPCR research

working on receptor targets Structural biologists Translational scientists Biotech and pharmaceutical researchers Postdoctoral fellows and graduate researchers entering drug discovery If you work directly with receptor For researchers working in biotech, pharma, or academia, this type of continuing education can strengthen

makes a reagent successful—and why academic–industry collaborations are essential for advancing GPCR research How collaborations with David Parker and Jean-Philippe Pin accelerated both probe chemistry and biological lies in turning cutting-edge probe chemistry into robust, scalable tools for drug discovery and basic research behind-the-scenes access to GPCR innovators, exclusive deep-dives, and practical tools to accelerate your research